United States
China
India
Japan
Singapore
South Africa
United Kingdom
As a leading publisher of trusted science, technology, medicine, humanities and social sciences research, Taylor & Francis is committed to helping public health authorities, researchers, clinicians and the general public contain and manage the spread of COVID-19.
This microsite provides links and references to all relevant COVID-19 research articles, book chapters and information that can be freely accessed on Taylor & Francis Online and Taylor & Francis ebooks in support of the global efforts in diagnosis, treatment, prevention and further research into COVID-19. As signatories to NIH’s Access to Research initiative, along with the Wellcome Trust’s coordinated action on sharing research data and findings relevant to the outbreak, Taylor & Francis has been working with WHO to ensure this content is clearly signposted. We are also aligning the OSTP’s initiative to centralise resources on PubMed and are currently working with them to ensure rapid human and machine-readable access (where possible) to research articles and data through the NLM’s LitCovid portal.
More research in this field has been collated by colleagues at F1000Research, through a dedicated Gateway which showcases research published in this area, including preprints, to ensure immediate access to the latest research developments https://f1000research.com/gateways/disease_outbreaks/coronavirus
Prioritising rapid publication of COVID-19 materials
We are working with our editors to prioritise peer review of all relevant research. We are also focusing our workflow to ensure that materials related to the outbreak are fast-tracked through the publication process once they are approved. Editors are proactively encouraging authors to publish and share the data that forms the basis of their research in line with FAIR data principles, and our own data policies.
We are continually monitoring the developments of the coronavirus and spread of COVID-19, and we will continue to update the content on this site on a regular basis.
Journals
1-221 of 4,900+ results.
Access the full Coronavirus Research Archive
- research-articleTocilizumab for the treatment of non‐critical COVID‐19 pneumonia: an overview of the rationale and clinical evidence to date
- article-commentarySARS-CoV-2 vaccination in the context of original antigenic sin
- research-articleHuman immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants
- research-articleTocilizumab in COVID-19: a study of adverse drug events reported in the WHO database
- research-articleBlood concentrations of proapoptotic sFas and antiapoptotic Bcl2 and COVID-19 patient mortality
- research-articleEmerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
- research-articleAssociation between Hb A1c and Severity of COVID-19 Patients
- research-articleIntegrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors
- research-articleIntegrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors
- research-articlePerformance of the FREND™ COVID-19 IgG/IgM Duo point-of-care test for SARS-CoV-2 antibody detection
- research-articleReported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST)
- otherUnleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination
- research-articleChemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications
- research-articleMolecular modeling of potent novel sulfonamide derivatives as non-peptide small molecule anti-COVID 19 agents
- research-articleHospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
- research-articleAre the new SARS-CoV-2 variants resistant against the vaccine?
- research-articlePotential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations
Books
- research-articleThe role of IL-6 and IL-6 blockade in COVID-19
- research-articleEngineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins
- research-articleVirtual screening of quinoline derived library for SARS-COV-2 targeting viral entry and replication
- review-articleLong COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
- research-articleMarine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery
- research-articleA large-scale computational screen identifies strong potential inhibitors for disrupting SARS-CoV-2 S-protein and human ACE2 interaction
- research-articleDistinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-19
- research-articlePerspective: the nose and the stomach play a critical role in the NZACE2-Pātari* (modified ACE2) drug treatment project of SARS-CoV-2 infection
- research-articleThe Glasgow Prognostic Score and fibrinogen to albumin ratio as prognostic factors in hospitalized patients with COVID-19
- research-articleComputational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings
- otherTapping the immunological imprints to design chimeric SARS-CoV-2 vaccine for elderly population
- case-reportHemorrhagic infarctive stroke in COVID-19 patients: report of two cases and review of the literature
- review-articleCOVID-19 pericarditis mimicking an acute myocardial infarction: a case report and review of literature
- research-articleThe effect of RAAS inhibitors on acute hypoxemic respiratory failure and in-hospital mortality in the hypertensive Covid-19 patients
- article-commentaryIs a single COVID-19 vaccine dose enough in convalescents ?
- article-commentaryExperimental studies using OMV in a new platform of SARS-CoV-2 vaccines
- research-articleMechanistic insights into the inhibitory activity of FDA approved ivermectin against SARS-CoV-2: old drug with new implications
- research-articleOutcomes of acute respiratory distress syndrome in COVID-19 patients compared to the general population: a systematic review and meta-analysis
- research-articleEpidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence
- research-articleImpact of influenza vaccination on the risk of SARS-CoV-2 infection in a middle-aged group of people
- review-articleImmunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update
- research-articleCOVID-19: captures iron and generates reactive oxygen species to damage the human immune system
- research-articleFalse-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives
- research-articleThe emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?
- research-articleThe diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis
- research-articleThe time to offer treatments for COVID-19
- review-articlePolymer-based nano-therapies to combat COVID-19 related respiratory injury: progress, prospects, and challenges
- research-articleCirculating Calprotectin as a Biomarker of COVID-19 Severity
- research-articleVisual scoring of chest CT at hospital admission predicts hospitalization time and intensive care admission in Covid-19
- research-articleInhibition of SARS-CoV-2 main protease: a repurposing study that targets the dimer interface of the protein
- research-articleColchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimens
- research-articleA risk score based on baseline risk factors for predicting mortality in COVID-19 patients
- research-articleElucidation of the inhibitory activity of ivermectin with host nuclear importin α and several SARS-CoV-2 targets
- article-commentaryPositive aspects of the mRNA platform for SARS-CoV-2 vaccines
- research-articleEfficacy and safety of Tocilizumab in severe and critical COVID-19: A Systematic Review and Meta-Analysis
- research-articleCircadian clock modulating small molecules repurposing as inhibitors of SARS-CoV-2 Mpro for pharmacological interventions in COVID-19 pandemic
- research-articleCircadian clock modulating small molecules repurposing as inhibitors of SARS-CoV-2 Mpro for pharmacological interventions in COVID-19 pandemic
- research-articleMR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19
- research-articleIncubation period of coronavirus disease 2019: new implications for intervention and control
- research-articleIn silico characterization of mutations circulating in SARS-CoV-2 structural proteins
- otherVitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits
- research-articleAsthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis
- research-articleDesign and synthesis of novel phe-phe hydroxyethylene derivatives as potential coronavirus main protease inhibitors
- research-articleCompounds of plants with activity against SARS-CoV-2 targets
- research-articleDiagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR
- otherASSURED-SQVM diagnostics for COVID-19: addressing the why, when, where, who, what and how of testing
- research-articleHigh sensitivity troponin and COVID-19 outcomes
- research-articleCOVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention
- research-articleMontelukast in hospitalized patients diagnosed with COVID-19
- article-commentaryβ-glucans: wide-spectrum immune-balancing food-supplement-based enteric (β-WIFE) vaccine adjuvant approach to COVID-19
- research-articlePharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH)
- research-articleCorticosteroids and tocilizumab reduce in-hospital mortality in severe COVID-19 pneumonia: a retrospective study in a Spanish hospital
- research-articleAn Evaluation of Serum 25-Hydroxy Vitamin D Levels in Patients with COVID-19 in New York City
- research-articleSARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department
- research-articleIn silico prediction of SARS-CoV-2 main protease and polymerase inhibitors: 3D-Pharmacophore modelling
- research-articleMetabolomic profiling of three Araucaria species, and their possible potential role against COVID-19
- research-articleLow Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study
- research-articleRepurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2
- research-articleAnti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment
- research-articleIn silico identification and validation of natural antiviral compounds as potential inhibitors of SARS-CoV-2 methyltransferase
- research-articleStructural genetics of circulating variants affecting the SARS-CoV-2 spike/human ACE2 complex
- research-articleUse of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials
- research-articleElevated serum ferritin level effectively discriminates severity illness and liver injury of coronavirus disease 2019 pneumonia
- research-articleAnalytical evaluation and critical appraisal of early commercial SARS-CoV-2 immunoassays for routine use in a diagnostic laboratory
- research-articleArtificially expanded genetic information systems (AEGISs) as potent inhibitors of the RNA-dependent RNA polymerase of the SARS-CoV-2
- research-articleThe relationship between positivity for COVID-19 RT-PCR and symptoms, clinical findings, and mortality in Turkey
- research-articlePDE3-inhibitor enoximone prevented mechanical ventilation in patients with SARS-CoV-2 pneumonia
- research-articlePredictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study
- research-articleImpact of dimerization and N3 binding on molecular dynamics of SARS-CoV and SARS-CoV-2 main proteases
- research-articleCorticosteroids treatment in severe patients with COVID-19: a propensity score matching study
- research-articleCorrelation between Micronutrient plasma concentration and disease severity in COVID-19 patients
- research-articleStructure of the multiple functional domains from coronavirus nonstructural protein 3
- research-articleSusceptibility of rabbits to SARS-CoV-2
- research-articleSARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay
- research-articleEmbedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience
- Original ResearchStructural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach
- Original ResearchDesign of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach
